Hjem › Multipelt myelom › New Jersey › Edison
Kliniske studier for Multipelt myelom i Edison, NJ
22 studier for Multipelt myelom søker deltakere på steder i og rundt Edison (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
A Study of Melphalan With or Without Siltuximab in People With Multiple Myeloma Having an Autologous Stem Cell Transplant
RekruttererFase 2
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge · 15 mi unna
A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma
RekruttererFase 3
- Astera Cancer Care, East Brunswick · 6 mi unna
A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma
RekruttererFase 3
- Astera Cancer Care, East Brunswick · 6 mi unna
A Study to Learn About the Effects of the Combination of Elranatamab, Daratumumab and Lenalidomide Compared With Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma Who Are Not Candidates for Transplant
RekruttererFase 3
- MSK Basking Ridge, Basking Ridge · 15 mi unna
A Long-term Study for Participants Previously Treated With Ciltacabtagene Autoleucel
RekruttererFase 4
- Rutgers Cancer Institute of New Jersey, New Brunswick · 3 mi unna
Study of IgPro20 to Prevent Infection in People With Multiple Myeloma and Hypogammaglobulinemia
RekruttererFase 2
- Memorial Sloan Kettering Basking Ridge (All Protocol Activities), Basking Ridge · 15 mi unna
Study of Arlocabtagene Autoleucel (BMS-986393) a GPRC5D-directed CAR T Cell Therapy in Adult Participants With Relapsed or Refractory Multiple Myeloma
RekruttererFase 2
- Rutgers Cancer Institute of New Jersey, New Brunswick · 3 mi unna
A Study to Learn About the Study Medicine Elranatamab Alone and With Daratumumab in People With Multiple Myeloma Who Have Received Other Treatments
RekruttererFase 3
- MSK Basking Ridge, Basking Ridge · 15 mi unna
A Study of Teclistamab and Mezigdomide in People With Multiple Myeloma
RekruttererFase 1
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge · 15 mi unna
Study of AZD0120 in Newly Diagnosed Multiple Myeloma Ineligible for ASCT
RekruttererFase 3
- Research Site, East Brunswick · 6 mi unna
A Study of Voice as a Way to Monitor for Side Effects in People Receiving CAR T-Cell Therapy
RekruttererObservasjonsstudie
- Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities), Basking Ridge · 15 mi unna
A Study of Dara-RVd and Teclistamab-RVd in People With Multiple Myeloma
RekruttererFase 1/2
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge · 15 mi unna
A Study of CyBorD (Cyclophosphamide, Bortezomib, Dexamethasone) Plus Daratumumab in People With Monoclonal Gammopathy of Renal Significance (MGRS)
RekruttererFase 2
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge · 15 mi unna
A Study of Elranatamab and Cyclophosphamide in People With Multiple Myeloma
RekruttererFase 2
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge · 15 mi unna
Loratadine for the Reduction of G-CSF Induced Bone Pain in Patients With Multiple Myeloma Undergoing Stem Cell Mobilization
RekruttererTidlig fase 1
- Rutgers Cancer Institute of New Jersey, New Brunswick · 3 mi unna
- RWJBarnabas Health - Robert Wood Johnson University Hospital, New Brunswick, New Brunswick · 3 mi unna
A Window of Opportunity Trial to Learn if Linvoseltamab is Safe and Well Tolerated, and How Well it Works in Adult Participants With Recently Diagnosed Multiple Myeloma Who Have Not Already Received Treatment
RekruttererFase 1/2
- Rutgers Cancer Institute of New Jersey, New Brunswick · 3 mi unna
Study of Intravenously (IV) Infused Etentamig in Combination With an Oral Cereblon E3 Ligase Modulatory Drug (CELMoD) Agent Assessing Adverse Events and Change in Disease Activity in Adult Participants With Relapsed or Refractory Multiple Myeloma
RekruttererFase 1
- Rutgers Cancer Institute of New Jersey /ID# 266833, New Brunswick · 3 mi unna
A Dietary Study for People With Multiple Myeloma
Rekrutterer
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge · 15 mi unna
A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
RekruttererFase 1/2
- Rutgers Cancer Institute of New Jersey, New Brunswick · 3 mi unna
A Study of Talquetamab for People With Multiple Myeloma Who Have Received BCMA CAR T-Cell Therapy
RekruttererFase 2
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge · 15 mi unna
Ascertainment of Families for Genetic Studies of Familial Lymphoproliferative Disorders
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
- Memorial Sloan Kettering Basking Ridge, Basking Ridge · 15 mi unna
A Study of a Plant-Based Diet and Dietary Supplements in People With Smoldering Multiple Myeloma (SMM) or Monoclonal Gammopathy of Undetermined Significance (MGUS)
Rekrutterer
- Memorial Sloan Kettering Basking Ridge (All Protocol Activities), Basking Ridge · 15 mi unna
Multipelt myelom-studier i andre byer
- New York City, NY60 studier
- Boston, MA42 studier
- Atlanta, GA41 studier
- Houston, TX38 studier
- Durham, NC37 studier
- Nashville, TN32 studier
- Denver, CO27 studier
- Rochester, MN24 studier
- St. Louis, MO24 studier
- Columbus, OH24 studier
- Baldwin Park, CA23 studier
- Chicago, IL22 studier
Andre studier i Edison
- Brystkreft68 studier
- Ikke-småcellet lungekreft47 studier
- Kreft (alle typer)33 studier
- Prostatakreft29 studier
- Kolorektal kreft23 studier
- Lungekreft23 studier
- Blærekreft21 studier
- Metastatisk kreft20 studier
- Eggstokkreft20 studier
- Akut myelogen leukemi20 studier
- Endometriekreft19 studier
- Urotelial (overgangscelle) karcinom18 studier
Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.